NYSE - Delayed Quote • USD agilon health, inc. (AGL) Follow Compare 2.2400 +0.0200 (+0.90%) At close: December 13 at 4:00:02 PM EST 2.2500 +0.01 (+0.45%) After hours: December 13 at 7:59:39 PM EST All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations Agilon Health price target lowered to $4 from $8 at Wells Fargo Wells Fargo lowered the firm’s price target on Agilon Health (AGL) to $4 from $8 and keeps an Overweight rating on the shares as the firm updates Managed Care estimates post-election. All estimates assume the expiration of enhanced exchange subsidies for 2026, Wells notes. The firm believes Medicare Advantage risk/reward improves with Republicans, although areas of concern still exist. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> agilon health Reports ACO REACH Model Results for 2023 Performance Year AUSTIN, Texas, November 12, 2024--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced that its Accountable Care Organizations (ACOs) achieved $150 million in gross savings (13% gross savings rate), including $37 million savings to the Medicare Trust Fund, during the 2023 performance year of the ACO Realizing Equity, Access and Community Health (ACO REACH) model. agilon’s eight REACH ACOs operate under full risk, and in Agilon Health Inc (AGL) Q3 2024 Earnings Call Highlights: Revenue Surge Amidst Margin Challenges Agilon Health Inc (AGL) reports a 28% revenue increase and membership growth, but faces profitability hurdles with lowered guidance. Here's What Key Metrics Tell Us About Agilon (AGL) Q3 Earnings Although the revenue and EPS for Agilon (AGL) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers. Agilon Health (AGL) Reports Q3 Loss, Lags Revenue Estimates Agilon (AGL) delivered earnings and revenue surprises of -190% and 1.29%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock? agilon health Reports Third Quarter 2024 Results AUSTIN, Texas, November 07, 2024--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, today announced results for the third quarter ended September 30, 2024. agilon health to Participate at 2024 Wolfe Research Healthcare Conference AUSTIN, Texas, November 05, 2024--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced that it will participate in the 2024 Wolfe Research Healthcare Conference including a fireside chat presentation on Tuesday, November 19, at 2:20 PM Eastern Time. agilon health Sets Date to Report Third Quarter 2024 Financial Results AUSTIN, Texas, October 17, 2024--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced that it will release its financial results for the third quarter 2024 after the market closes on Thursday, November 7, 2024, and host a conference call at 4:30 PM Eastern Time the same day to discuss the results. Insider Stock Buying Reaches US$815.1k On agilon health It is usually uneventful when a single insider buys stock. However, When quite a few insiders buy shares, as it... Agilon Health Inc. (AGL): Fast-Growing Penny Stock To Consider We recently compiled a list of the 10 Best Fast-Growing Penny Stocks to Buy Now. In this article, we are going to take a look at where Agilon Health Inc. (NYSE:AGL) stands against the fast-growing penny stocks. Rate Cuts Are Around the Corner September tends to be the worst month for the stock market, however 2024 […] FMR LLC's Strategic Reduction in Agilon Health Inc Shares On August 30, 2024, FMR LLC (Trades, Portfolio) executed a significant transaction by reducing its stake in Agilon Health Inc (NYSE:AGL), a key player in the healthcare sector. This adjustment reflects a substantial -50.54% change in FMR LLC (Trades, Portfolio)'s investment in Agilon, impacting its portfolio by a mere -0.01%. agilon health to Participate at 2024 Wells Fargo Healthcare Conference AUSTIN, Texas, August 21, 2024--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced that it will participate in the 2024 Wells Fargo Healthcare Conference, including a fireside chat presentation on Wednesday, September 4, at 3:00 PM Eastern Time. agilon health Second Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag agilon health ( NYSE:AGL ) Second Quarter 2024 Results Key Financial Results Revenue: US$1.48b (up 29% from 2Q 2023... Q2 2024 agilon health inc Earnings Call Q2 2024 agilon health inc Earnings Call Agilon (AGL) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates While the top- and bottom-line numbers for Agilon (AGL) give a sense of how the business performed in the quarter ended June 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values. Agilon Health (AGL) Reports Q2 Loss, Misses Revenue Estimates Agilon (AGL) delivered earnings and revenue surprises of 0% and 4.85%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock? Agilon: Q2 Earnings Snapshot AUSTIN, Texas (AP) — Agilon Health Inc. AGL) on Tuesday reported a loss of $30.7 million in its second quarter. On a per-share basis, the Austin, Texas-based company said it had a loss of 7 cents. agilon health Reports Second Quarter 2024 Results AUSTIN, Texas, August 06, 2024--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced results for the second quarter ended June 30, 2024. agilon health Sets Date to Report Second Quarter 2024 Financial Results AUSTIN, Texas, July 23, 2024--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced that it will release its financial results for the second quarter 2024 after the market closes on Tuesday, August 6, 2024, and host a conference call at 4:30 PM Eastern Time the same day to discuss the results. agilon health Appoints Karthik Rao, M.D., as Chief Medical Officer AUSTIN, Texas, July 10, 2024--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced today that after a comprehensive search Karthik Rao, M.D., who has served as agilon’s interim chief medical officer (CMO) since February 2024, has been appointed to the permanent CMO role, effective immediately. He previously served as senior medical director and vice president, network performance, at the company. Performance Overview Trailing total returns as of 12/13/2024, which may include dividends or other distributions. Benchmark is S&P 500 Return AGL S&P 500 YTD -82.15% +26.86% 1-Year -81.82% +30.31% 3-Year -90.20% +28.42%